Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Melia

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
JAMA Ophthalmology|March 23, 2023
Evaluating the Evidence for Treatment of Meibomian Gland Dysfunction With Oral AntibioticsB Michele Melia
JAMA Ophthalmology|November 15, 2019
Time to Consider Adoption of New Retinopathy of Prematurity Screening Guidelines in the United StatesB Michele Melia
JAMA Ophthalmology|August 25, 2022
Is Glasses Wear Protective Against COVID-19?B Michele Melia
Ophthalmology|December 11, 2008
Post hoc power calculationsDavid K Wallace, Michele Melia
JAMA Ophthalmology|September 27, 2014
Randomizing 1 eye or 2 eyes: a missed opportunityAdam R Glassman, Michele Melia
JAMA Ophthalmology|August 21, 2015
Considerations for randomizing 1 eye or 2 eyes--replyAdam R Glassman, Michele Melia
BMC Ophthalmology|June 9, 2006
Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]Hossein Bahrami, Michele Melia, Gislin Dagnelie
Investigative Ophthalmology & Visual Science|July 29, 2003
Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularizationHiroyuki Nambu, Rie Nambu, Michele Melia, et al.
Ophthalmology|December 22, 2005
Is there an association between diabetes and keratoconus?Irene C Kuo, Aimee Broman, Ashkan Pirouzmanesh, et al.
JAMA Ophthalmology|January 31, 2015
Evaluation of the Intermittent Exotropia Questionnaire using Rasch analysisDavid A Leske, Jonathan M Holmes, B Michele Melia, et al.
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
JAMA Ophthalmology|March 23, 2023
Evaluating the Evidence for Treatment of Meibomian Gland Dysfunction With Oral AntibioticsB Michele Melia
JAMA Ophthalmology|November 15, 2019
Time to Consider Adoption of New Retinopathy of Prematurity Screening Guidelines in the United StatesB Michele Melia
JAMA Ophthalmology|August 25, 2022
Is Glasses Wear Protective Against COVID-19?B Michele Melia
Ophthalmology|December 11, 2008
Post hoc power calculationsDavid K Wallace, Michele Melia
JAMA Ophthalmology|September 27, 2014
Randomizing 1 eye or 2 eyes: a missed opportunityAdam R Glassman, Michele Melia
JAMA Ophthalmology|August 21, 2015
Considerations for randomizing 1 eye or 2 eyes--replyAdam R Glassman, Michele Melia
BMC Ophthalmology|June 9, 2006
Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]Hossein Bahrami, Michele Melia, Gislin Dagnelie
Investigative Ophthalmology & Visual Science|July 29, 2003
Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularizationHiroyuki Nambu, Rie Nambu, Michele Melia, et al.
Ophthalmology|December 22, 2005
Is there an association between diabetes and keratoconus?Irene C Kuo, Aimee Broman, Ashkan Pirouzmanesh, et al.
JAMA Ophthalmology|January 31, 2015
Evaluation of the Intermittent Exotropia Questionnaire using Rasch analysisDavid A Leske, Jonathan M Holmes, B Michele Melia, et al.
Pageof 14